Page 2659 - Saunders Comprehensive Review For NCLEX-RN

Cardiovascular findings, in liver dysfunction 633f

Cardiovascular medications 737–754
adrenergic agonists 748, 748b

adrenergic blockers 743, 743b

β-adrenergic blockers 745, 745b
angiotensin-converting enzyme inhibitors 743–744, 743b

angiotensin II receptor blockers 743–744, 743b
antianginal medications 744–745, 744b

anticoagulants 737–738, 738b
antidysrhythmic medications 747–748

antihypertensive medications 741–742, 741–742b

antilipemic medications 748–749, 749b
antiplatelet medications 739, 739b
calcium channel blockers 745–746, 745b

cardiac glycosides 740–741

centrally acting sympatholytics 743, 743b
diuretics 741–742, 741–742b

peripherally acting α-adrenergic blockers 742–743, 742b
positive inotropic and cardiotonic medications 739–740, 740b, 740f

thrombolytic medications 738–739, 738b
vasodilators

direct-acting, arteriolar 746–747, 746b

miscellaneous 747
peripheral 746, 746b

Cardiovascular system 696–736
acidosis manifestations in 113t

alkalosis manifestations in 113t
anaphylaxis manifestations in 901f

anatomy and physiology of 696–698
assessment of, in newborn 344

changes in, with aging 248
chronic kidney disease manifestation in 763b

diagnostic tests and procedures 698–702

disorders of

2659